PCR ribotypes of Clostridioides difficile across Texas from 2011 to 2018 including emergence of ribotype 255

References

• Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis. 2008 Jan 15;46(Suppl 1):S4–11. doi: 10.1086/521865
   PubMed Web of Science ®Google Scholar
• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015 Feb 26;372(9):825–834. doi: 10.1056/NEJMoa1408913
   PubMed Web of Science ®Google Scholar
• McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018 Mar 19;66(7):e1–e48. doi: 10.1093/cid/cix1085
   PubMed Web of Science ®Google Scholar
• Wilcox MH, Shetty N, Fawley WN, et al. Changing epidemiology of Clostridium difficile infection following the introduction of a national ribotyping-based surveillance scheme in England. Clin Infect Dis. 2012 Oct;55(8):1056–1063. doi: 10.1093/cid/cis614
   PubMed Web of Science ®Google Scholar
• Feazel LM, Malhotra A, Perencevich EN, et al. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother. 2014 Jul;69(7):1748–1754. doi: 10.1093/jac/dku046
   PubMed Web of Science ®Google Scholar
• Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005 Sep 24–30;366(9491):1079–1084. doi: 10.1016/S0140-6736(05)67420-X
   PubMed Web of Science ®Google Scholar
• Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med. 1999 Nov 25;341(22):1645–1651. doi: 10.1056/NEJM199911253412203
   PubMed Web of Science ®Google Scholar
• Pear SM, Williamson TH, Bettin KM, et al. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med. 1994 Feb 15;120(4):272–277. doi: 10.7326/0003-4819-120-4-199402150-00003
   PubMed Web of Science ®Google Scholar
• Aldeyab MA, Devine MJ, Flanagan P, et al. Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol. 2011 Mar;32(3):210–219. doi: 10.1086/658333
   PubMed Web of Science ®Google Scholar
• Katz KC, Golding GR, Choi KB, et al. The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009–2015). CMAJ. 2018 Jun 25;190(25):E758–E765. doi: 10.1503/cmaj.180013
   PubMed Web of Science ®Google Scholar
• Bauer MP, Notermans DW, van Benthem BHB, et al. Clostridium difficile infection in Europe: a hospital-based survey. The Lancet. 2011;377(9759):63–73. doi: 10.1016/S0140-6736(10)61266-4
   PubMed Web of Science ®Google Scholar
• Health Protection Agency. Clostridium Difficile Ribotyping Network (CDRN) for England and Northern Ireland 2015 to 2018; 2019. [cited 2019 July 3]. Available from: https://www.gov.uk/government/publications/clostridium-difficile-ribotyping-network-cdrn-report.
   Google Scholar
• Centers for Disease Control and Prevention. 2017 Annual report for the emerging infections program for Clostridium difficile infection; 2017. [cited 2019 Sep 4]. Available from: https://www.cdc.gov/hai/eip/Annual-CDI-Report-2017.html.
   Google Scholar
• Imwattana K, Knight DR, Kullin B, et al. Clostridium difficile ribotype 017 – characterization, evolution and epidemiology of the dominant strain in Asia. Emerg Microbes Infect. 2019;8(1):796–807. doi: 10.1080/22221751.2019.1621670
   PubMed Web of Science ®Google Scholar
• Collins DA, Hawkey PM, Riley TV. Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control. 2013;2(1):21. doi: 10.1186/2047-2994-2-21
   PubMed Web of Science ®Google Scholar
• Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010 Jul;23(3):529–549. doi: 10.1128/CMR.00082-09
   PubMed Web of Science ®Google Scholar
• Freeman J, Vernon J, Pilling S, et al. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011–2014. Clin Microbiol Infect. 2018 Jul;24(7):724–731. doi: 10.1016/j.cmi.2017.10.008
   PubMed Web of Science ®Google Scholar
• Cassir N, Fahsi N, Durand G, et al. Emergence of Clostridium difficile tcdC variant 078 in Marseille, France. Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1971–1974. doi: 10.1007/s10096-017-3022-8
   PubMed Web of Science ®Google Scholar
• Spigaglia P, Barbanti F, Dionisi AM, et al. Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018. J Clin Microbiol. 2010 Aug;48(8):2892–2896. doi: 10.1128/JCM.02482-09
   PubMed Web of Science ®Google Scholar
• Public Health England. Clostridium Difficile Ribotyping Network (CDRN) service [updated April 12, 2017; cited 2019 Sep 5]. Available from: https://www.gov.uk/government/collections/clostridium-difficile-ribotyping-network-cdrn-service.
   Google Scholar
• Endres BT, Dotson KM, Poblete K, et al. Environmental transmission of Clostridioides difficile ribotype 027 at a long-term care facility; an outbreak investigation guided by whole genome sequencing. Infect Control Hosp Epidemiol. 2018;39(11):1322–1329. doi: 10.1017/ice.2018.230
   PubMed Web of Science ®Google Scholar
• Aitken SL, Alam MJ, Khaleduzzaman M, et al. In the endemic setting, Clostridium difficile ribotype 027 is virulent but not hypervirulent. Infect Control Hosp Epidemiol. 2015 Nov;36(11):1318–1323. doi: 10.1017/ice.2015.187
   PubMed Web of Science ®Google Scholar
• Alam MJ, Walk ST, Endres BT, et al. Community environmental contamination of toxigenic clostridium difficile. Open Forum Infect Dis. 2017 Winter;4(1):ofx018. doi: 10.1093/ofid/ofx018
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Multidrug-resistant organism and Clostridioides difficile infection (MDRO/CDI) module. 2019.
   Google Scholar
• Tickler IA, Goering RV, Whitmore JD, et al. Strain types and antimicrobial resistance patterns of Clostridium difficile isolates from the United States, 2011 to 2013. Antimicrob Agents Chemother. 2014 Jul;58(7):4214–4218. doi: 10.1128/AAC.02775-13
   PubMed Web of Science ®Google Scholar
• Cheknis A, Johnson S, Chesnel L, et al. Molecular epidemiology of Clostridioides (Clostridium) difficile strains recovered from clinical trials in the US, Canada and Europe from 2006–2009 to 2012–2015. Anaerobe. 2018 Oct;53:38–42. doi: 10.1016/j.anaerobe.2018.05.009
   PubMed Web of Science ®Google Scholar
• Tickler IA, Obradovich AE, Goering RV, et al. Changes in molecular epidemiology and antimicrobial resistance profiles of Clostridioides (Clostridium) difficile strains in the United States between 2011 and 2017. Anaerobe. 2019 Jun 4. Available from: https://doi.org/10.1016/j.anaerobe.2019.06.003.
   PubMed Web of Science ®Google Scholar
• Snydman DR, McDermott LA, Thorpe CM, et al. Antimicrobial susceptibility and ribotypes of Clostridium difficile isolates from a Phase 2 clinical trial of ridinilazole (SMT19969) and vancomycin. J Antimicrob Chemother. 2018 Aug 1;73(8):2078–2084. doi: 10.1093/jac/dky135
   PubMed Web of Science ®Google Scholar
• Snydman DR, McDermott LA, Jenkins SG, et al. Epidemiologic trends in Clostridium difficile isolate ribotypes in United States from 2010 to 2016. San Diego (CA): IDWeek; 2017.
   Google Scholar
• Rao K, Micic D, Natarajan M, et al. Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis. 2015 Jul 15;61(2):233–241. doi: 10.1093/cid/civ254
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Clostridioides difficile infection (CDI) Tracking; 2019. [cited 2019 July 3]. Available from: https://www.cdc.gov/hai/eip/cdiff-tracking.html.
   Google Scholar
• Spinler JK, Gonzales-Luna AJ, Raza S, et al. Complete genome sequence of Clostridioides difficile ribotype 255 strain Mta-79, assembled using Oxford nanopore and Illumina sequencing. Microbiol Resour Announc. 2019 Oct 17;8(42):e00935-19. doi: 10.1128/MRA.00935-19
   Web of Science ®Google Scholar
• Chitnis AS, Holzbauer SM, Belflower RM, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013 Jul 22;173(14):1359–1367. doi: 10.1001/jamainternmed.2013.7056
   PubMed Web of Science ®Google Scholar
• Magill SS, O'Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018 Nov 1;379(18):1732–1744. doi: 10.1056/NEJMoa1801550
   PubMed Web of Science ®Google Scholar